The National Coalition for Appropriate Prescribing (led by the Prescription Project – a sister organization to us here at Prescription Access Litigation) is working to pass the Physician Payments Sunshine Act, a transparency bill requiring pharmaceutical companies to publicly report their gifts and payments to doctors. The Senate version of the bill is here and the House version is here.

Pharmaceutical and medical device industry marketing to doctors (well over $30 billion each year) takes the form of gifts, honoraria and other payments. This spending subtly and not-so-subtly induces doctors to prescribe newer and more expensive treatments, regardless of whether they’re better. This in turn drives up drug costs and puts patients at risk, because new and heavily marketed drugs are almost always more expensive, even though they are often no more effective than older, established therapies. Newer drugs may also have unknown side effects.

We believe the public deserves to know how much money individual physicians are accepting from industry. (Disclosure laws in Minnesota and Vermont reveal that many doctors receive industry payments of thousands or tens of thousands of dollars a year.) The Sunshine Act will benefit patients, payers, policy makers and taxpayers alike by creating transparency.

Key provisions include:

  • Comprehensive and publicly available reporting of information down to the individual prescriber level;
  • A low ($25) threshold for reporting; inclusion of all payments; and
  • penalties for companies that don’t report.

Sign this petition today to ask your members of Congress to support these bills:

For more information:

  • To learn more about industry payments to doctors click here
  • For factsheets on the Sunshine Act House and Senate bills click here
  • To see the organizations that are members of the National Coalition for Appropriate Prescribing click here

Sign the petition